Canprev Inno-Q-Nol ( CoQ10 Ubiquinol ) 60 soft gels

Canprev's Inno-Q-Nol® products feature ubiquinol, the most bioactive form of coenzyme Q10 (CoQ10). Backed by over 30 years of clinical research, Inno-Q-Nol® is enhanced with a unique Q-Nol® process. This includes ascorbyl palmitate (vitamin C), medium chain triglycerides, and annatto seed extract. This 3 tier approach ensures the CoQ10 ubiquinol in Inno-Q-Nol® remains not only active but guaranteed stable for highest potency.

Key Benefits:

• Reduce the risk for cardiovascular disease
• Boost energy levels
• Provide antioxidant protection
• Reduce oxidative stress
• Blood sugar support
• Respiratory function
• Chronic fatigue
• Muscle fatigue
• Cognitive support (headaches)
• Fertility health

About CoQ10

Coenzyme Q10 is responsible for fueling our cellular mitochondria - the energy powerhouses of our cells. There are two types of CoQ10 that exist naturally in our body; ubiquinone and ubiquinol. Both can be found in supplement form. Though both forms of CoQ10 are beneficial, there are key elements to consider when choosing a form to supplement with. Ubiquinone in the body acts as an oxidized form of CoQ10 and in supplement form it remains fat soluble and is unstable as well. This form can be converted into the active form known as ubiquinol - more readily utilized by the body. Aging and other factors like, stress, oxidative damage and increased usage of prescription medication inhibit the conversion process from ubiquinone to ubiquinol in the body.

Canprev's active and body-ready form of ubiquinol can be utilized without any conversion process. Active ubiquinol is highly effective for helping to reduce cellular oxidation. Human clinical studies have shown that when compared to standard CoQ10 supplements, ubiquinol is: 8x better absorbed in the bloodstream; reduces exercise-induced fatigue by 90%; and slows aging by 40%. But, because of its nature, ubiquinol is also unstable and can easily be converted back into its oxidized form.

That’s where Inno-Q-Nol® becomes highly valuable. Inno-Q-Nol® features a patented process to help shield stability against oxidation. This involves a three-tier approach that keeps ubiquinol stable. It includes ascorbyl palmitate (vitamin C) to stop internal oxidation, medium chain triglycerides for overall stability, and annatto seed extract within the capsule to provide a neutralizing oxidative barrier that helps prevent against external oxidation. A body ready form of CoQ10 guaranteed to be as stable as it can possibly be, for highest potency and effectiveness.

The INNO-Q-NOL® CoQ10 Family

Powered by the patented  Q-Nol® process (US Patent 6,740,338) which ensures ubiquinol in the finished product stays stable (i.e. as ubiquinol) through to product expiration, the INNO-Q-Nol® family of products also includes INNO-Q-NOL® Blood Pressure and INNO-Q-NOL® Carntine.

This year, heart disease will affect more women in Canada than any other disease.  Cardiovascular afflictions can include atherosclerosis, hypertension, stroke and heart attack.

For over 30 years, Innovite has been inspiring wellness. When the body’s core systems work in synergy, optimal health can be achieved. Our goal to nourish and heal the body from the inside out: restoring nutrients and repairing damage so you can reclaim your health. Our nutritional foundation is built from the latest research and clinical evidence. 

INNO-Q-NOL® 100 mg
Medicinal Ingredients:

Each softgel contains

INNO-Q-NOL® 200 mg
Medicinal Ingredients:

Each softgel contains

For all potencies and sizes:
Non medicinal Ingredients: Ascorbyl palmitate, Medium chain triglycerides, Annatto, Gelatin, Glycerin, White beeswax, Sunflower lecithin, Sunflower oil, purified water.

QUALITY, PURITY AND POTENCY GUARANTEED.
Free from wheat, gluten, corn, nuts, peanuts, dairy, eggs, fish, shellfish, yeast, sugar, starch, soy, GMO, artificial colours, flavours and preservatives.

Kaneka QH® is a trademark of Kaneka Corporation.

The use of ascorbyl palmitate to guarantee stability of ubiquinol is covered by US Patent 6,740,338.